From GLP-1 to Keto, hear the nutrition tips and recipes you need to stay on track in the New Year IRVING, Texas, Jan. 14, 2026

Post Content

But the labels — unlike the popular medications themselves — aren’t regulated by the FDA.

by Ariana M. Chao, Adam Gilden, Thomas A. Wadden Glucagon-like peptide-1 (GLP-1)-based medications, such as semaglutide and tirzepatide, have transformed obesity care. However, rising use

The rising popularity of weight loss drugs is a key reason healthcare company Eli Lilly (NYSE: LLY) has been soaring in value in recent years.

Novo Nordisk’s CEO spoke about GLP-1 pricing and Pfizer’s CEO spoke about the company’s obesity ambitions while at the JPMorgan Healthcare Conference.

We have heard Reddit horror stories about GLP-1 users losing their hair. Now, there’s finally a study corroborating these claims. The researchers concluded that patients

In the three years since Ozempic entered the national consciousness, the brand name has become so ubiquitous that it is used as a shorthand for

While the nutritional needs of GLP-1 users are not drastically different from the general population, according to a dietician, the key distinction lies in reduced

WEDNESDAY, Jan. 14, 2026 — More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a glucagon-like peptide-1

Bariatric surgery and GLP-1 treatments reshape body composition differently, emphasizing the importance of sex and treatment choice in muscle preservation.

The rise and riseof GLP-1 medications, why lived experiences are important in the context of mental health and why the new US dietary guidelines should

Brand hopes chef can boost appeal among nutrient-conscious foodies.

SALT LAKE CITY, Jan. 14, 2026 /PRNewswire/ — Shed, a leading health and wellness platform focused on accessible, clinician-guided care, today announced the expansion of

Research shows that people who stop taking GLP-1 medications regain weight within 2 years. Image Credit: Tatsiana Volkava/Getty Images A new study has found that

Good morning, everyone, the middle of the week has arrived and this calls for a celebratory cup or two of stimulation. How so? Well, you

South Africa is a study in contrasts. And the 2026 public health agenda is no exception.  Breakthrough HIV prevention medicine has arrived alongside US funding

The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out for 2026,

Tucker Carlson’s gaunt appearance sparks Ozempic rumours as weight-loss drugs become mainstream. Explore the latest speculation and why celebrities are turning to GLP-1 medications.

The FDA is requesting that drugmakers remove suicidal ideation and behavior warnings from the labeling of three GLP-1 receptor agonists — Saxenda (liraglutide), Wegovy (semaglutide)

Food Funct., 2026, Advance ArticleDOI: 10.1039/D6FO90005D, Correction Open Access   This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Hong Hu, Jie

Texas-founded partnership debuts a 12-week GLP-1 + food-as-medicine program built for sustainable metabolic health and employer-ready deployment AUSTIN, Texas, Jan. 14, 2026 /PRNewswire/ — Nimbus

Dr Bhojraj explains that GLP-1 isn’t a medication but a natural hormone, and while it can help, they have side effects and aren’t meant for

4 Mistakes People Make When Starting a GLP-1 That Can Stall Weight Loss—Plus How to Maximize Your Results  Woman’s World Study Finds More Than a Quarter

Federal regulators have told drugmakers Novo Nordisk and Eli Lilly to remove label warnings about potential suicidal thoughts and behaviours from their blockbuster weight-loss medications.

New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve outcomes for people who do develop the

Samsung Biologics CEO John Rim delivers his keynote speech outlining the company’s future roadmap at the 44th J.P. Morgan Health Care Conference held at Westin

> It’s insane to me that so many people need these to get off the processed foods killing them in the US The American diet

GLP-1 receptor agonist prescribing increases between 2019 and 2024. Medscape Medical News

SAN FRANCISCO—They met for the first time in 2018. David A. Ricks, a year into his tenure as Eli Lilly’s Chair and CEO, hosted Jensen

[previously in series: 1, 2, 3, 4, 5, 6, 7, 8] Every city parties for its own reasons. New Yorkers party to flaunt their wealth.

Humana’s CenterWell Pharmacy will distribute Eli Lilly obesity medications under a new program targeting employers, according to a Jan. 12 news release. The pharmacy will serve those

(MedPage Today) — The FDA requested that manufacturers of GLP-1 receptor agonists remove information regarding risks of suicidal behavior and ideation from drug labels following

FDA calls on GLP-1 drugmakers to remove suicide warnings  Axios US FDA requests removal of suicide warnings from weight-loss drugs  CNN US FDA requests removal of suicide

The FDA asked Novo Nordisk and Eli Lilly to remove warnings about suicidal ideation or behavior from the labels of their blockbuster GLP-1 weight loss

Americans are drinking less than ever—and a growing share are teetotalers. What’s behind the trend? What do the numbers show? That the U.S. is losing

A study of 227 individuals who experienced neurocognitive difficulties post COVID-19 infection—such as headaches, vertigo, balance dysregulation, changes in taste/smell, and brain fog—displayed a significant

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer.

The sound of a fire alarm tells us to get out quickly to not get hurt, while the sight of a gas station sign can